Adelene Q Perkins - Net Worth and Insider Trading
Adelene Q Perkins Net Worth
The estimated net worth of Adelene Q Perkins is at least $0 dollars as of 2024-11-05. Adelene Q Perkins is the Director of Infinity Pharmaceuticals Inc and owns about 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Adelene Q Perkins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adelene Q Perkins has not made any transactions after 2023-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adelene Q Perkins
Adelene Q Perkins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adelene Q Perkins owns 2 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) , and Bruker Corp (BRKR) .
Click here to see the complete history of Adelene Q Perkins’s form 4 insider trades.
Insider Ownership Summary of Adelene Q Perkins
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2023-09-12 | director & President & CEO |
BRKR | Bruker Corp | 2017-05-22 | director |
Adelene Q Perkins Latest Holdings Summary
Adelene Q Perkins currently owns a total of 1 stock. Adelene Q Perkins owns 1,191,738 shares of Infinity Pharmaceuticals Inc (INFIQ) as of September 12, 2023, with a value of $0.
Latest Holdings of Adelene Q Perkins
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2023-09-12 | 1,191,738 | 0.00 | 0 |
Holding Weightings of Adelene Q Perkins
Adelene Q Perkins Form 4 Trading Tracker
According to the SEC Form 4 filings, Adelene Q Perkins has made a total of 1 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 410,196 shares on September 12, 2023, which brought Adelene Q Perkins around $28,714.
Insider Trading History of Adelene Q Perkins
- 1
Adelene Q Perkins Trading Performance
GuruFocus tracks the stock performance after each of Adelene Q Perkins's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adelene Q Perkins is 6.24%. GuruFocus also compares Adelene Q Perkins's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adelene Q Perkins within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adelene Q Perkins's insider trading performs compared to the benchmark.
Performance of Adelene Q Perkins
Adelene Q Perkins Ownership Network
Ownership Network List of Adelene Q Perkins
Ownership Network Relation of Adelene Q Perkins
Adelene Q Perkins Owned Company Details
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Adelene Q Perkins is the director & President & CEO of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include Chief Scientific Officer Stephane Peluso , Chief Medical Officer Robert Jr. Ilaria , and other: See Explanation of Responses Biotechnology Value Fund L P .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
Over the past 18 months, Adelene Q Perkins made 1 insider transaction in Infinity Pharmaceuticals Inc (INFIQ) with a net sale of 410,196.
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
Adelene Q Perkins Mailing Address
Above is the net worth, insider trading, and ownership report for Adelene Q Perkins. You might contact Adelene Q Perkins via mailing address: C/o Infinity Pharmaceuticals, Inc., 780 Memorial Drive, Cambridge Ma 02139.